These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16274947)

  • 41. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA; Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
    Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients.
    Remenar JF; Wenslow R; Ostovic D; Peresypkin A
    Pharm Res; 2004 Jan; 21(1):185-8. PubMed ID: 14984274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of powder substrate on foaml drainage and collapse: implications to foam granulation.
    Koo OM; Ji J; Li J
    J Pharm Sci; 2012 Apr; 101(4):1385-90. PubMed ID: 22234920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The utilization of surface free-energy parameters for the selection of a suitable binder in fluidized bed granulation.
    Planinsek O; Pisek R; Trojak A; Srcic S
    Int J Pharm; 2000 Oct; 207(1-2):77-88. PubMed ID: 11036233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An investigation into the rheology of pharmaceutical inter-granular material bridges at high shear rates.
    Crean B; Chen X; Banks SR; Cook WG; Melia CD; Roberts CJ
    Pharm Res; 2009 May; 26(5):1101-11. PubMed ID: 19189204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing the efficiency of polymeric excipients by atomistic molecular dynamics simulations.
    Jha PK; Larson RG
    Mol Pharm; 2014 May; 11(5):1676-86. PubMed ID: 24708235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients.
    Kim I; Kim H; Park K; Karki S; Khadka P; Jo K; Kim SY; Ro J; Lee J
    Drug Dev Ind Pharm; 2016; 42(2):231-7. PubMed ID: 26023993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. True density analysis of a freeze-dried amorphous sugar matrix.
    Imamura K; Maruyama Y; Tanaka K; Yokoyama T; Imanaka H; Nakanishi K
    J Pharm Sci; 2008 Jul; 97(7):2789-97. PubMed ID: 17918722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of pharmaceutical excipients with supercritical fluid extraction.
    Ashraf-Khorassani M; Taylor LT; Waterman KC; Narayan P; Brannegan DR; Reid GL
    Pharm Dev Technol; 2005; 10(4):507-16. PubMed ID: 16370180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrinsic adhesion properties of poly(vinyl pyrrolidone) to pharmaceutical materials: humidity effect.
    Lee J
    Macromol Biosci; 2005 Nov; 5(11):1085-93. PubMed ID: 16245267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rheologic properties of some pharmaceutical excipients in drug forms and cosmetic preparation technology].
    Tsagareishvili GV; Bashura AA; Alekseeva MA; Bashura GS
    Georgian Med News; 2012 Jun; (207):57-62. PubMed ID: 22859452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thermodynamic models, describing formation of "bridges" between nucleic acid molecules and liquid crystals].
    Nechipurenko IuD; Riabokon' VF; Semenov SV; Evdokimov IuM
    Biofizika; 2003; 48(4):635-43. PubMed ID: 14515481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inverse gas chromatographic determination of solubility parameters of excipients.
    Adamska K; Voelkel A
    Int J Pharm; 2005 Nov; 304(1-2):11-7. PubMed ID: 16183222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound].
    Angyal N; Terdy L; Varga Z; Akos K; Bódis A
    Acta Pharm Hung; 2004; 74(1):45-50. PubMed ID: 15524048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amorphous pharmaceutical solids: preparation, characterization and stabilization.
    Yu L
    Adv Drug Deliv Rev; 2001 May; 48(1):27-42. PubMed ID: 11325475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries.
    Gift AD; Luner PE; Luedeman L; Taylor LS
    J Pharm Sci; 2008 Dec; 97(12):5198-211. PubMed ID: 18449917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scale-up of wet kneading in a novel vertical high shear kneader.
    Watano S; Okamoto T; Sato Y; Ohnishi Y; Yasutomo T; Osako Y
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):18-21. PubMed ID: 15635222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.